secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANGIODYNAMICS INC (ANGO)
CIK:        0001275187
Form:       8-K
Filed at:   2023-03-30T23:59:59+00:00
Accession:  0000914121-23-000149
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AngioDynamics Q3 net sales up 9% but guides down; adjusted EPS loss $0.03 vs prior guidance for profit
--------------------------------------------------------------------------------

- Q3 net sales $80.7M (+9.1% YoY); GAAP loss per share $0.24 vs $0.13 loss last year; adjusted loss per share $0.03.
- Med Tech sales $22.9M (+16.6%); Auryon +42.8% to $10.4M; AngioVac -15.7% to $5.5M.
- Gross margin 50.2%, down 200 bps YoY; adjusted EBITDA $4.3M vs $6.7M.
- FY2023 guidance cut: net sales now $338-342M (from $342-348M); adjusted EPS now loss $0.06 to loss $0.01 (from profit $0.01-0.06).
- Cash $30.1M; total debt $50M; generated $1.4M operating cash in Q3.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1275187/000091412123000149/0000914121-23-000149-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1275187/000091412123000149/an59017198-8ki.htm
  HTML page:      https://secwatch.observer/filing/0000914121-23-000149

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer